Gloveless or Less Gloves? Regulatory Trends and Automated Solutions
The following article is part 2 of a blog series that has been adapted from AST’s VP of Sales and Marketing Josh Russell’s recent article in Cleanroom Technology. In part 1, we discussed considerations for isolator configurations and AST’s approach to integrating automation in our new barrier technology solution. The most important questions to consider […]
Gloveless or Less Gloves? A Real-World Approach to Optimizing Fill-Finish Automation
The following 2-part blog series has been adapted from AST’s VP of Sales and Marketing Josh Russell’s recent article in Cleanroom Technology.
Live from New York: Debuting a 100 % AST Turnkey Solution
The AST team recently returned from New York City, the site of Interphex 2024, and to say we came back motivated would be an understatement. The show was teeming with enthusiasm as life sciences professionals from across the globe gathered in the Big Apple for the premier pharmaceutical and biotechnology event. The stage was set […]
Isolator Air Handling: Advancements and Considerations for Fill-Finish Processing
In the fill-finish manufacturing of parenteral liquid pharmaceuticals, maintaining product sterility is paramount. The choice of what kind of barrier technology to utilize becomes key, as operations must account for the production environment and the level of control and efficiency needed to hit key production milestones. For an increasing amount of industry professionals, isolators are […]
The Quest for Sterility Assurance: A New Approach to Isolator Decontamination
One of the more challenging, essential aspects of planning for an isolated fill-finish operation is determining the approach to decontamination. Sterility assurance is a top priority, and ensuring a selected method meets regulatory thresholds is vital.
American-Made, Worldwide Benefit: Raising the Bar in Isolated Fill-Finish Manufacturing
When AST produced its first fill-finish solution in 2006, two key convictions drove that early innovation: A commitment to imagining a never-before-seen aseptic multi-format processing system that was versatile and flexible, and a desire to produce robust, American-made aseptic fill-finish products. Ahead of the release of our new isolator, we wanted to explore our commitment […]
CURIS System and AST Unite to Redefine Aseptic Fill-Finish Processing Technology
**For Immediate Release** Oviedo, Florida, and Tacoma, Washington, February 5, 2024 – CURIS System, an innovator in advanced decontamination technology, and AST, a leader in aseptic fill-finish processing technology, today announced a groundbreaking partnership. This collaboration marks a significant step forward in the pharmaceutical manufacturing industry, as the two companies combine technology to revolutionize the […]
The Next-Generation Isolator: A User-Friendly Solution for Fill-Finish Professionals
When AST came to the table on the design for our new fill-finish isolator, one of the first areas AST engineers wanted to address was the usability and accessibility of the isolator and corresponding operations. With our customers’ point of view in mind, we wanted to address specific points of friction routinely encountered by operators […]
AST Perspectives: Reimagining Fill-Finish Isolator Design
By Steven Ng, CTO & VP of Customer Service This past October, AST announced a groundbreaking collaboration with Germfree on a new fill-finish isolator. This exciting announcement was the result of just over a year of brainstorming, research, and development, as our team at AST set out to create an isolator solution that would meet […]
From Startup to Standout: Aseptic Processing Solutions for Life Science Innovators
The path to a successful life science startup is exciting, difficult, and unpredictable. Recent years have seen a volatile pattern emerge of challenge, change and innovation within the life sciences. The trend towards innovative pharmaceutical solutions is projected to continue into 2024, as breakthroughs in treatment modalities, supply chain management and patient-centered medicine are tracking […]